• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病大脑中含有具有不同类朊病毒样活性的 tau 片段。

Alzheimer's disease brain contains tau fractions with differential prion-like activities.

机构信息

Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY, 10314, USA.

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education of China, Co-Innovation Center of Neuroregeneration, 19 Qixiu Road, Nantong, 226001, Jiangsu, China.

出版信息

Acta Neuropathol Commun. 2021 Feb 17;9(1):28. doi: 10.1186/s40478-021-01127-4.

DOI:10.1186/s40478-021-01127-4
PMID:33597014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7890974/
Abstract

Neurofibrillary tangles (NFTs) made of abnormally hyperphosphorylated tau are a hallmark of Alzheimer's disease (AD) and related tauopathies. Regional distribution of NFTs is associated with the progression of the disease and has been proposed to be a result of prion-like propagation of misfolded tau. Tau in AD brain is heterogenous and presents in various forms. In the present study, we prepared different tau fractions by sedimentation combined with sarkosyl solubility from AD brains and analyzed their biochemical and pathological properties. We found that tau in oligomeric fraction (O-tau), sarkosyl-insoluble fractions 1 and 2 (SI-tau and SI-tau) and monomeric heat-stable fraction (HS-tau) showed differences in truncation, hyperphosphorylation, and resistance to proteinase K. O-tau, SI-tau, and SI-tau, but not HS-tau, were hyperphosphorylated at multiple sites and contained SDS- and β-mercaptoethanol-resistant high molecular weight aggregates, which lacked the N-terminal portion of tau. O-tau and SI-tau displayed more truncation and less hyperphosphorylation than SI-tau. Resistance to proteinase K was increased from O-tau to SI-tau to SI-tau. O-tau and SI-tau, but not SI-tau or HS-tau, captured tau from cell lysates and seeded tau aggregation in cultured cells. Heat treatment could not kill the prion-like activity of O-tau to capture normal tau. Hippocampal injection of O-tau into 18-month-old FVB mice induced significant tau aggregation in both ipsilateral and contralateral hippocampi, but SI-tau only induced tau pathology in the ipsilateral hippocampus, and SI-tau and HS-tau failed to induce any detectable tau aggregation. These findings suggest that O-tau and SI-tau have prion-like activities and may serve as seeds to recruit tau and template tau to aggregate, resulting in the propagation of tau pathology. Heterogeneity of tau pathology within AD brain results in different fractions with different biological and prion-like properties, which may pose a major challenge in targeting tau for development of effective therapeutic treatments.

摘要

神经原纤维缠结(NFTs)由异常过度磷酸化的 tau 组成,是阿尔茨海默病(AD)和相关 tau 病的标志。NFT 的区域分布与疾病的进展有关,并被提出是错误折叠 tau 类病毒样传播的结果。AD 脑中的 tau 是异质的,呈现出多种形式。在本研究中,我们通过从 AD 脑中的沉淀和 Sarkosyl 可溶性分离,制备了不同的 tau 分数,并分析了它们的生化和病理特性。我们发现,寡聚体(O-tau)、Sarkosyl 不溶性分数 1 和 2(SI-tau 和 SI-tau)以及单体热稳定分数(HS-tau)中的 tau 在截断、过度磷酸化和对蛋白酶 K 的抗性方面存在差异。O-tau、SI-tau 和 SI-tau(但不是 HS-tau)在多个位点过度磷酸化,并含有 SDS 和 β-巯基乙醇抗性高分子量聚集体,这些聚集体缺乏 tau 的 N 端部分。O-tau 和 SI-tau 的截断程度高于 SI-tau,过度磷酸化程度低于 SI-tau。对蛋白酶 K 的抗性从 O-tau 到 SI-tau 再到 SI-tau 增加。O-tau 和 SI-tau(但不是 SI-tau 或 HS-tau)从细胞裂解物中捕获 tau,并在培养细胞中引发 tau 聚集。热处理不能杀死 O-tau 捕获正常 tau 的类病毒样活性。将 O-tau 注入 18 个月大的 FVB 小鼠的海马中,导致双侧海马中均发生明显的 tau 聚集,但 SI-tau 仅在同侧海马中引起 tau 病理学改变,而 SI-tau 和 HS-tau 均未引起任何可检测到的 tau 聚集。这些发现表明,O-tau 和 SI-tau 具有类病毒样活性,可能作为招募 tau 和模板 tau 聚集的种子,导致 tau 病理学的传播。AD 脑中 tau 病理学的异质性导致不同的分数具有不同的生物学和类病毒样特性,这可能对靶向 tau 以开发有效的治疗方法构成重大挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/e7e0260f7621/40478_2021_1127_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/58510fad8c36/40478_2021_1127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/ba83099c19cf/40478_2021_1127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/b34084895c77/40478_2021_1127_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/f0e0e1af015c/40478_2021_1127_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/5e66e5f2f683/40478_2021_1127_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/46cdc6ad57cc/40478_2021_1127_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/56b0698d6342/40478_2021_1127_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/19e05939442b/40478_2021_1127_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/e7e0260f7621/40478_2021_1127_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/58510fad8c36/40478_2021_1127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/ba83099c19cf/40478_2021_1127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/b34084895c77/40478_2021_1127_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/f0e0e1af015c/40478_2021_1127_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/5e66e5f2f683/40478_2021_1127_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/46cdc6ad57cc/40478_2021_1127_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/56b0698d6342/40478_2021_1127_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/19e05939442b/40478_2021_1127_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/470b/7890974/e7e0260f7621/40478_2021_1127_Fig9_HTML.jpg

相似文献

1
Alzheimer's disease brain contains tau fractions with differential prion-like activities.阿尔茨海默病大脑中含有具有不同类朊病毒样活性的 tau 片段。
Acta Neuropathol Commun. 2021 Feb 17;9(1):28. doi: 10.1186/s40478-021-01127-4.
2
Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.阿尔茨海默病和 3xTg-AD 小鼠脑组织中 Tau 的病理改变。
Mol Neurobiol. 2019 Sep;56(9):6168-6183. doi: 10.1007/s12035-019-1507-4. Epub 2019 Feb 8.
3
Truncation of Tau selectively facilitates its pathological activities.截断 Tau 选择性地促进其病理性活动。
J Biol Chem. 2020 Oct 2;295(40):13812-13828. doi: 10.1074/jbc.RA120.012587. Epub 2020 Jul 31.
4
Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau .来自阿尔茨海默病大脑的病理性tau蛋白诱导tau蛋白位点特异性过度磷酸化以及对SDS和还原剂具有抗性的聚集。
Front Aging Neurosci. 2019 Mar 5;11:34. doi: 10.3389/fnagi.2019.00034. eCollection 2019.
5
Pathological Changes of Tau Related to Alzheimer's Disease.tau 相关的阿尔茨海默病的病理变化。
ACS Chem Neurosci. 2019 Feb 20;10(2):931-944. doi: 10.1021/acschemneuro.8b00457. Epub 2018 Oct 23.
6
Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation.靶向微管结合域的 Tau 抗体 77G7 抑制蛋白病理 Tau 以引发 Tau 聚集。
CNS Neurosci Ther. 2022 Dec;28(12):2245-2259. doi: 10.1111/cns.13970. Epub 2022 Sep 17.
7
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.tau 接近连接分析显示,在临床前阿尔茨海默病神经原纤维缠结之前存在广泛的先前未检测到的病理。
Acta Neuropathol Commun. 2021 Jan 28;9(1):18. doi: 10.1186/s40478-020-01117-y.
8
Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.Aβ 诱导的阿尔茨海默病相关 tau 病理扩散加速及其与朊病毒蛋白的关系。
Acta Neuropathol. 2019 Dec;138(6):913-941. doi: 10.1007/s00401-019-02053-5. Epub 2019 Aug 14.
9
Hyperphosphorylation determines both the spread and the morphology of tau pathology.过度磷酸化决定了 tau 病理的扩散和形态。
Alzheimers Dement. 2016 Oct;12(10):1066-1077. doi: 10.1016/j.jalz.2016.01.014. Epub 2016 Apr 28.
10
Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.阿尔茨海默病脑灰质与白质中的播散性 Tau。
J Alzheimers Dis. 2021;79(4):1647-1659. doi: 10.3233/JAD-201290.

引用本文的文献

1
Rational Modulation of Liquid-Liquid Phase Separation Offers Novel Ways to Combat Tauopathies.液-液相分离的合理调控为对抗tau蛋白病提供了新方法。
Int J Mol Sci. 2025 Jul 12;26(14):6709. doi: 10.3390/ijms26146709.
2
Cytoskeletal Proteins and Alzheimer's Disease Pathogenesis: Focusing on the Interplay with Tau Pathology.细胞骨架蛋白与阿尔茨海默病发病机制:聚焦于与tau病理的相互作用
Biomolecules. 2025 Jun 6;15(6):831. doi: 10.3390/biom15060831.
3
Novel strategies for targeting tau oligomers in neurodegenerative diseases.针对神经退行性疾病中tau寡聚体的新策略。

本文引用的文献

1
Truncation of Tau selectively facilitates its pathological activities.截断 Tau 选择性地促进其病理性活动。
J Biol Chem. 2020 Oct 2;295(40):13812-13828. doi: 10.1074/jbc.RA120.012587. Epub 2020 Jul 31.
2
Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.阿尔茨海默病和 3xTg-AD 小鼠脑组织中 Tau 的病理改变。
Mol Neurobiol. 2019 Sep;56(9):6168-6183. doi: 10.1007/s12035-019-1507-4. Epub 2019 Feb 8.
3
Inert and seed-competent tau monomers suggest structural origins of aggregation.无定型和有种子能力的 tau 单体提示了聚集的结构起源。
J Neurol. 2025 May 8;272(6):383. doi: 10.1007/s00415-025-13117-w.
4
Alzheimer's disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery.阿尔茨海默病患者脑提取物在新型血管化神经免疫类器官中诱发多种病理变化,用于疾病建模和药物发现。
Mol Psychiatry. 2025 May 2. doi: 10.1038/s41380-025-03041-w.
5
The Peptide PROTAC Modality: A New Strategy for Drug Discovery.肽类PROTAC技术:药物发现的新策略。
MedComm (2020). 2025 Mar 24;6(4):e70133. doi: 10.1002/mco2.70133. eCollection 2025 Apr.
6
Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer's patients postmortem is associated with abnormal iron homeostasis: implications for patient survival.阿尔茨海默病患者死后颞叶皮质中钙/钙调蛋白依赖性蛋白激酶激酶2、转铁蛋白和转铁蛋白受体蛋白的缺失与铁稳态异常有关:对患者生存的影响。
Front Cell Dev Biol. 2024 Nov 28;12:1469751. doi: 10.3389/fcell.2024.1469751. eCollection 2024.
7
Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer's disease tau seeds have distinct properties.水可提取的无纤维和 Sarkosyl 可提取的纤维状阿尔茨海默病 Tau 种子具有不同的特性。
Acta Neuropathol Commun. 2024 Sep 9;12(1):145. doi: 10.1186/s40478-024-01849-1.
8
MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross-seeding ability.与家族性 tau 病相关的 MAPT 突变导致形成构象不同的寡聚物,这些寡聚物具有交叉种籽能力。
Protein Sci. 2024 Sep;33(9):e5099. doi: 10.1002/pro.5099.
9
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.tau 蛋白聚集之谜:机制见解与未来挑战。
Int J Mol Sci. 2024 May 2;25(9):4969. doi: 10.3390/ijms25094969.
10
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.塑造成功治疗阿尔茨海默病的疾病修饰药物的临床前开发的未来:tau 传播模型的系统评价。
Acta Neuropathol Commun. 2024 Apr 4;12(1):52. doi: 10.1186/s40478-024-01748-5.
Elife. 2018 Jul 10;7:e36584. doi: 10.7554/eLife.36584.
4
Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.tau 种子活性首先出现在(transentorhinal/entorhinal)区域,并且可预测阿尔茨海默病和 PART 中的磷酸化 tau 病理学。
Acta Neuropathol. 2018 Jul;136(1):57-67. doi: 10.1007/s00401-018-1855-6. Epub 2018 May 11.
5
Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.tau 蛋白水解在 tau 病发病机制中的作用:神经毒性片段和新型生物标志物。
J Alzheimers Dis. 2018;63(1):13-33. doi: 10.3233/JAD-170959.
6
Widespread tau seeding activity at early Braak stages.在Braak早期阶段广泛存在的tau蛋白播种活动。
Acta Neuropathol. 2017 Jan;133(1):91-100. doi: 10.1007/s00401-016-1644-z. Epub 2016 Nov 22.
7
Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.来自阿尔茨海默病大脑的独特病理性tau构象在非转基因小鼠中传播tau病理。
J Exp Med. 2016 Nov 14;213(12):2635-2654. doi: 10.1084/jem.20160833. Epub 2016 Oct 17.
8
Hyperphosphorylation determines both the spread and the morphology of tau pathology.过度磷酸化决定了 tau 病理的扩散和形态。
Alzheimers Dement. 2016 Oct;12(10):1066-1077. doi: 10.1016/j.jalz.2016.01.014. Epub 2016 Apr 28.
9
PET Imaging of Tau Deposition in the Aging Human Brain.衰老人类大脑中tau蛋白沉积的正电子发射断层显像(PET)成像
Neuron. 2016 Mar 2;89(5):971-982. doi: 10.1016/j.neuron.2016.01.028.
10
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.候选 tau PET 配体 18F-AV-1451 的区域特征再现了 Braak 组织病理学分期的关键特征。
Brain. 2016 May;139(Pt 5):1539-50. doi: 10.1093/brain/aww023. Epub 2016 Mar 2.